The paradox of motion: why some patients struggle to stay still

History · Published 19 October 2026 Swipe more like this →

In short: Imagine a neurological disorder where the primary struggle is not a lack of movement, but an inability to stop it. Tardive dyskinesia turns medication into a physical burden, causing involuntary grimacing, tongue protrusion, and limb jerks that can make walking impossible. It is a complex, iatrogenic dance of dopamine.

Tardive dyskinesia (TD) is an iatrogenic disorder, meaning it is caused by medical treatment—specifically the long-term use of dopamine-receptor-blocking medications like antipsychotics. While these drugs are essential for managing mental illnesses like schizophrenia, they can trigger repetitive, involuntary movements such as chorea or athetosis. The condition typically manifests only after months or years of treatment, often appearing as grimacing, smacking of the lips, or rapid movements of the limbs and torso.

The underlying mechanism is a subject of ongoing research. One prominent theory is dopamine supersensitivity in the nigrostriatal pathway, where the D2 receptor becomes hypersensitive after being blocked for long periods. However, because the time-course of TD and its prevalence in older populations suggest a more complex etiology, researchers also point to oxidative stress as a significant causal factor. Individual risk varies wildly based on genetic polymorphisms, prior exposure to environmental toxins, and 'functional reserve'—which can be diminished by aging, alcohol use, or traumatic head injuries.

The stakes are high: in some cases, the movements are so severe that walking becomes difficult or impossible. Additionally, neurological disorders like TD are commonly mistaken for psychiatric conditions. This mistake can lead to the prescription of more antipsychotics, which ironically increases the probability of developing a severe, disabling case and can shorten a patient's typical survival period. While some symptoms may resolve after stopping the medication, others can persist for years or become permanent.

Prevention and management involve a delicate balance. Doctors aim for the lowest effective dose, but for chronic psychosis, higher doses are often necessary to prevent relapse. Treatment options include switching to low-risk agents like clozapine, using dopamine-depleting drugs like valbenazine (FDA-approved in 2017), or even botulinum toxin for minor focal dystonia. Because the disorder is so closely related to variants like tardive dystonia and tardive akathisia, clinicians often use the Abnormal Involuntary Movement Scale (AIMS), constructed in the 1970s, to track severity over time.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• Parkinsonism is a broad clinical syndrome, not just the disease that shares its name.
• Akathisia is a restlessness so intense its name means 'cannot sit'
• Touching the chin can briefly switch off some dystonia spasms
• The dance of the immune system: why children move like marionettes
• Dyspraxia affects about one in twenty people and has nothing to do with intelligence
• Why the ancient Egyptians worshipped a terrifying hybrid beast as a protector of life
• The global obsession with chewy tapioca pearls began as a humble, cheaper sago substitute.
• The Temple of Artemis was a marvel that survived floods, fire, and shifting empires
• How a former captive became the most powerful woman in the Mongol Empire
• Tezcatlipoca, the Smoking Mirror, was the Aztec deity of conflict, night, and transformation.
• Why Sweden’s most notorious fermented herring is a masterclass in controlled chemical decay
• Why some empires rule the waves instead of the land beneath their feet

More in Empires & civilisations · More in History · Latest · A–Z · All topics